纳米酶在阿尔茨海默病诊断和治疗中的作用
Linquan Li1, Wenyu Zhang1, Hengyi Cao1
1School of Clinical and Basic Medical Sciences, Medical Science and Technology Innovation Center, Shandong Provincial Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250000, China. zhengrunxiao@sdfmu.edu.cn.
Biomaterials science
|July 31, 2024
概括
纳米酶为阿尔茨海默病 (AD) 提供了一个有前途的解决方案,使早期诊断和有针对性的治疗成为可能. 本综述探讨了用于AD诊断和治疗的各种纳米酶,强调了它们克服当前局限性的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有重大的全球健康影响.
- 目前的AD治疗主要是治疗症状,缺乏病因向,导致副作用和有限的早期诊断.
- 现有的AD诊断方法依赖于临床症状和成像,阻碍了早期检测.
研究的目的:
- 审查阿尔茨海默病 (AD) 诊断和治疗纳米酶的最新进展.
- 在AD的背景下分析各种纳米酶的诊断和治疗能力.
- 讨论基于纳米酶的AD干预相关的临床前景和挑战.
主要方法:
- 关于纳米酶应用于阿尔茨海默病的最新文献的综述.
- 纳米酶的分析具有类似过氧化酶,超氧化物异变酶和类似催化酶的活动.
- 纳米酶的分类包括黄金,铁,二氧化,和基系统.
主要成果:
- 纳米酶在阿尔茨海默症的诊断和治疗中表现出高稳定性和特异性.
- 各种纳米酶,包括黄金,铁,二氧化,和,在AD管理中显示出潜力.
- 纳米酶为阿尔茨海默病的早期检测和病因治疗提供了双重方法.
结论:
- 纳米酶是解决阿尔茨海默病诊断和治疗方面的挑战的一个有希望的前沿.
- 进一步的研究和开发对于克服挑战和实现纳米酶对AD的临床潜力至关重要.
- 本综述提供了一个全面的概述,以帮助研究人员推进对AD的纳米酶应用.
相关概念视频
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
114
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
114